Medicare Enrolled
Dr. Haritha Reddy, M.D.
Student in an Organized Health Care Education/Training Program · Grand Rapids, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reddy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reddy
Dr. Haritha Reddy is a student in an organized health care education/training program specialist in Grand Rapids, MI, with 12 years of NPI registration. Based on federal Medicare data, Dr. Reddy performed 2,714 Medicare services across 686 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reddy received a total of $6,408 from 31 pharmaceutical and/or device companies across 94 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 2% volume in MI
$6,408 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,714
Medicare services
Top 2% in MI for student in an organized health care education/training program
686
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~226 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
734 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 520 | $1 | $33 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
207 | $8 | $16 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
165 | $11 | $34 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
147 | $8 | $26 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
133 | $10 | $35 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
114 | $86 | $292 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
107 | $118 | $264 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
103 | $79 | $189 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
65 | $7 | $25 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
63 | $77 | $70 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
53 | $92 | $180 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
46 | $47 | $142 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
44 | $28 | $101 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
41 | $20 | $66 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
32 | $10 | $38 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
29 | $1 | $2 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
26 | $19 | $47 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
25 | $43 | $151 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
22 | $5 | $16 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $63 | $133 |
| New patient office visit, complex (60-74 min) | 11 | $136 | $324 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $134 | $304 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.3% high complexity
57.9% medium
33.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,408
Total received (2021-2024)
Avg $1,602/year across 4 years
Top 5% in MI for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
94
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,573 (71.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,823 (28.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$810
2023
$247
2022
$3,964
2021
$1,387
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$180
Novartis Pharmaceuticals Corporation
$108
PFIZER INC.
$76
E.R. Squibb & Sons, L.L.C.
$67
Gilead Sciences, Inc.
$40
ABBVIE INC.
$38
Celgene Corporation
$35
Amneal Pharmaceuticals LLC
$29
Daiichi Sankyo Inc.
$29
Merck Sharp & Dohme LLC
$29
Takeda Pharmaceuticals U.S.A., Inc.
$28
PROGENICS PHARMACEUTICALS, INC.
$25
Eisai Inc.
$25
GlaxoSmithKline, LLC.
$23
Lilly USA, LLC
$22
BeiGene USA, Inc.
$21
Rigel Pharmaceuticals, Inc.
$18
Fresenius Kabi USA, LLC
$17
Top 3 companies account for 45.0% of 2024 payments
All-time payments by company (2021-2024) ›
Gilead Sciences, Inc.
$1,756
Daiichi Sankyo Inc.
$1,575
Seagen Inc.
$1,428
Novartis Pharmaceuticals Corporation
$188
AstraZeneca Pharmaceuticals LP
$180
PFIZER INC.
$155
Merck Sharp & Dohme LLC
$135
Pharmacyclics LLC, an AbbVie Company
$91
E.R. Squibb & Sons, L.L.C.
$80
Genentech USA, Inc.
$75
Lilly USA, LLC
$60
ABBVIE INC.
$59
Incyte Corporation
$55
Amneal Pharmaceuticals LLC
$54
Takeda Pharmaceuticals U.S.A., Inc.
$49
Pharmacyclics LLC, An AbbVie Company
$49
JAZZ PHARMACEUTICALS INC.
$46
PharmaEssentia USA Corporation
$45
BeiGene USA, Inc.
$40
Janssen Biotech, Inc.
$39
Celgene Corporation
$35
Amgen Inc.
$28
PROGENICS PHARMACEUTICALS, INC.
$25
Eisai Inc.
$25
Astellas Pharma US Inc
$24
GlaxoSmithKline, LLC.
$23
GENZYME CORPORATION
$20
Rigel Pharmaceuticals, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$17
Fresenius Kabi USA, LLC
$17
AVEO Pharmaceuticals, Inc.
$14
Top 3 companies account for 74.3% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · AVASTIN · BESREMI · BOSULIF · BRUKINSA · Blincyto · CALQUENCE · DARZALEX · ENHERTU · EPKINLY · Enhertu · FOTIVDA · IBRANCE · IMBRUVICA · INLYTA · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · LIBTAYO · LUTATHERA · Lenvima · MEKINIST · OPDIVO · PADCEV · PYLARIFY · Perjeta · REBLOZYL · Rezlidhia · SCEMBLIX · Stimufend · TUKYSA · Trodelvy · VENCLEXTA · VERZENIO · Vitrakvi · XTANDI · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (71%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for student in an organized health care education/training program in MI.
Geographic Context
Student in an organized health care education/training programs within 10 mi
492
Per 100K population
74.7
County median income
$80,390
Nearest hospital
SPECTRUM HEALTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reddy is a mixed practice specialist, with above-average Medicare volume (top 2% in MI), with consulting-driven industry engagement in the top 5% of MI peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reddy experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Reddy performed 734 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reddy receive payments from pharmaceutical companies?
Yes. Dr. Reddy received a total of $6,408 from 31 companies across 94 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reddy's costs compare to other student in an organized health care education/training programs in Grand Rapids?
Dr. Reddy's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Grand Rapids
Browse student in an organized health care education/training programs in Grand Rapids ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in MI
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in MI
Which MI student in an organized health care education/training programs receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology